Status:
COMPLETED
Studying Genes to Identify Melanoma in Patients in Iceland and Their Family Members
Lead Sponsor:
Iceland Genomics Corporation
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Melanoma (Skin)
Eligibility:
All Genders
Brief Summary
RATIONALE: Studying the genes expressed in samples of blood from patients with cancer and their family members may help doctors identify biomarkers related to cancer. PURPOSE: This clinical trial is ...
Detailed Description
OBJECTIVES: * Assess the feasibility of Iceland Genomics Corporation (UVS) to identify melanoma in multiple-case families, individuals with multiple tumors, and selected additional family members in ...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Patients diagnosed with melanoma and selected family members are eligible to participate
- Must live in Iceland
- PATIENT CHARACTERISTICS:
- Not specified
- PRIOR CONCURRENT THERAPY:
- Not specified
Exclusion
Key Trial Info
Start Date :
October 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2009
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT00346008
Start Date
October 1 2005
End Date
February 1 2009
Last Update
May 30 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Iceland Genomics Corporation
Reykjavik, Iceland, 105